Pharmaceuticals

We are committed to addressing the most pressing healthcare needs in the Middle East and, therefore, work to provide advanced treatments across a wide range of therapeutic areas, including cardiology, ophthalmology and neurology, in addition to a comprehensive oncology portfolio covering haematology and radiology. Bayer is also a leading pharmaceutical provider for women’s health and reproductive healthcare therapies in the region. Today, Bayer’s Pharmaceuticals Division ranks among the top 10 biopharmaceutical companies in the Middle East.

Read more about the Global Pharmaceuticals Division.

Innovation and Technology

Bayer’s innovation has always been driven by our employees. We are committed to discovering and developing breakthrough treatments through the expertise of our scientists and strategic partners. By combining advances in biology, chemistry, data science, and artificial intelligence, Bayer stands at the forefront of innovation in life sciences, enabling us to increase the productivity of our research and development.

Guided by science and committed to patient care, Bayer strives to overcome the limitations of medical treatment, ushering in a new era where science and technology meet. By driving transformative innovation at every step, Bayer seeks to address the individual needs of every patient in order to achieve health for all and sustain it.

Key Collaborations and Initiatives

We aspire to collaborate with the brightest creative minds to develop innovative solutions for disease prevention and treatment, and to improve patients’ lives through digital and health technologies.